Humana Inc (HUM) Stock Forecast Oct. 16, 2026
Analysis updated on Oct. 16, 2026 (UTC) · Alpha · vs marketSwitch to Total · NYSE
Humana Inc (HUM) stock forecast summary
On Oct. 16, 2026, HUM is rated Neutral: its 90-day Alpha forecast sits in the middle 30% of the 5171 stocks scored that day.
Humana Inc is a large-cap company with a market capitalization of $51.99B. It ranks number 4 by market capitalization among the 10 Hospital & Medical Service Plans issuers in our coverage with a current forecast. Its Current Ratio of 1.77x is the highest of the 10 peers that report one.
For HUM, the Spearman rank correlation between our 90-day forecasts and the returns that followed is 43.0%, measured on 357 forecast dates between 2022-07-29 and 2026-07-17 on this stock's own recent history. A rank correlation runs from -100% to +100%: it measures whether higher forecasts were followed by higher returns, and a value near zero or below means the model has shown little skill on this stock. On the 30-day forecasts the same correlation is 30.0%, measured on 400 forecast dates between 2022-07-29 and 2026-09-16. Across our coverage, the out-of-sample test on 4495 stocks from 2025-01-06 to 2026-07-07 produced a positive net return in 82.5% of rebalance periods (factor-neutral book, net of estimated costs). Full backtest report
Expected return relative to the market over the horizon: a positive alpha means the model expects the stock to beat the market, whatever the market does. Ratings: strong buy ≥ +1.7%, buy ≥ +0.2%, sell < -0.9%, strong sell < -1.2% (top 15%, next 20%, middle 30%, next 20%, bottom 15% of the 2026-10-16 signals)
A free account shows the exact forecast, rating and rank of 3 tickers you follow, HUM included.
Follow HUM freeHUM price chart and AI forecast
How HUM ranks among 5171 stocks
90D Alpha forecasts of every company scored, cut into five relative ratings at the 15th, 35th, 65th and 85th percentiles (dashed lines).
Humana Inc (HUM) fundamentals
Trailing twelve months. The industry median and the rank (1 = highest) are taken over the Hospital & Medical Service Plans peers listed below that report each metric.
Valuation & Market
| Metric | HUM | Rank |
|---|---|---|
| Market Cap | $51.99B | 4/10 |
| P/E Ratio | 46.13x | 3/7 |
| P/B Ratio | 2.80x | 6/10 |
| Dividend Yield | 0.83% | – |
| EPS | $9.37 | – |
| Book Value/Share | $154.46 | – |
| Revenue/Share | $1140.57 | – |
| FCF/Share | $10.57 | – |
Profitability & Margins
| Metric | HUM | Rank |
|---|---|---|
| ROE | 6.1% | 5/8 |
| ROA | 2.0% | 6/8 |
| ROIC | 7.2% | 5/10 |
| Operating Margin | 1.8% | 5/10 |
| Net Margin | 0.8% | 6/8 |
| EBT Margin | 1.0% | 6/10 |
| Tax Rate | 17.5% | – |
Financial Health
| Metric | HUM | Rank |
|---|---|---|
| Current Ratio | 1.77x | 1/10 |
| D/E Ratio | 1.97x | 7/10 |
| Financial Leverage | 2.98x | 7/10 |
| Interest Coverage | 12.3x | 2/9 |
| Working Capital | $16.57B | 2/10 |
Cash Flow
| Metric | HUM | Rank |
|---|---|---|
| Operating Cash Flow | $1.84B | 6/10 |
| Free Cash Flow | $1.27B | 5/9 |
| Capital Spending | -$572M | 6/9 |
| OCF Growth YoY | -35.8% | 9/9 |
| FCF Growth YoY | -46.6% | 8/8 |
| FCF/Sales | 0.9% | 8/9 |
| CapEx/Sales | 0.4% | 5/9 |
Operational Efficiency
| Metric | HUM | Rank |
|---|---|---|
| Asset Turnover | 2.48x | 4/10 |
| Receivables Turnover | 26.3x | 2/6 |
| Fixed Assets Turnover | 63.2x | 7/10 |
| Days Sales Outstanding | 14 days | 5/6 |
Income Statement
| Metric | HUM | Rank |
|---|---|---|
| Total Revenue | $137.20B | 5/10 |
| Operating Income | $2.44B | 4/10 |
| Net Income | $1.13B | 4/8 |
| SG&A Expense | $16.09B | 3/8 |
Dividend & Shareholder Information
| Metric | HUM | Rank |
|---|---|---|
| Dividends Per Share | $3.57 | – |
| Payout Ratio | 38.1% | – |
| Shares Outstanding | 120M | – |
| Net Income Growth | -33.9% | 5/7 |
| EPS Growth | -33.9% | 5/7 |
Balance Sheet Highlights (USD millions)
| Total Current Assets | $38.08B | 68.9% of assets |
| Cash & Short-term Investments | $4.95B | 9.0% of assets |
| Accounts Receivable | $5.22B | 9.4% of assets |
| Total Liabilities | $36.63B | 66.3% of assets |
HUM quarterly financials and insider trading
Humana Inc (HUM) industry peers
Companies classified under the same SEC industry code as Humana Inc (Hospital & Medical Service Plans): 10 common-stock issuers with a forecast this week, one row per issuer, largest first. This is a classification match, not a curated list of competitors.
Reveal all forecasts · See exact % predictions for all competitors
Sign up free| Company | 90-Day AI Forecast (Alpha) | Market Cap |
|---|---|---|
| HUM Humana Inc | ▶ | $51.99B |
| UNH Unitedhealth Group Inc | ▲ | $365.02B |
| ELV Elevance Health, Inc. | ▶ | $92.88B |
| CI Cigna Group | ▶ | $79.88B |
| CNC Centene Corp | ▶ | $34.16B |
| MOH Molina Healthcare, Inc. | ▶ | $11.09B |
| OSCR Oscar Health, Inc. | ▲ | $10.33B |
| CLOV Clover Health Investments, Corp. /De | ▲ | $2.38B |
| ALHC Alignment Healthcare, Inc. | ▲ | $1.72B |
| TRUP Trupanion, Inc. | ▶ | $1.22B |
Where HUM sits on the market map
Humana Inc (HUM) stock news
Loading...
Humana Inc (HUM) stock forecast FAQ
What is the Humana Inc (HUM) stock forecast?
On Oct. 16, 2026, HUM is rated Neutral: its 90-day Alpha forecast sits in the middle 30% of the 5171 stocks scored that day.
How accurate are Humana Inc stock predictions?
For HUM, the Spearman rank correlation between our 90-day forecasts and the returns that followed is 43.0%, measured on 357 forecast dates between 2022-07-29 and 2026-07-17 on this stock's own recent history. A rank correlation runs from -100% to +100%: it measures whether higher forecasts were followed by higher returns, and a value near zero or below means the model has shown little skill on this stock. On the 30-day forecasts the same correlation is 30.0%, measured on 400 forecast dates between 2022-07-29 and 2026-09-16. Across our coverage, the out-of-sample test on 4495 stocks from 2025-01-06 to 2026-07-07 produced a positive net return in 82.5% of rebalance periods (factor-neutral book, net of estimated costs). Full backtest report
How often are Humana Inc forecasts updated?
Humana Inc forecasts are refreshed on trading days as the daily model run completes. The forecast on this page was produced on Oct. 16, 2026.
Which companies are Humana Inc's industry peers?
10 issuers in our coverage, HUM included, share the SEC industry code Hospital & Medical Service Plans. The largest are: Unitedhealth Group Inc (UNH), Elevance Health, Inc. (ELV), Cigna Group (CI), Centene Corp (CNC), Molina Healthcare, Inc. (MOH), Oscar Health, Inc. (OSCR).
This analysis is generated automatically using our proprietary AI systems and should not be considered personalized investment advice. Past performance does not guarantee future results. Always conduct your own research and consider consulting a financial advisor before making investment decisions.